Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

49982

	registered interest
	date	06/05/2014
	answering body	Department for Transport
	answering dept id	27
	answering dept short name	Transport
	answering dept sort name	Transport
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Transport, how many individuals applied to have their licences restored following the voluntary or enforced revocation of a driving licence on medical grounds in the most recent period for which figures are available; what the average timescale was for an application to be decided in that period; and how many requests were outstanding.
	tabling member constituency	Lancaster and Fleetwood
	tabling member printed	Eric Ollerenshaw
	uin	197757
	answer	answer is ministerial correction date of answer 13/05/2014 answer text <p> </p><p>The tables below show the number of drivers that have voluntarily surrendered, or had their driving licence refused/ revoked on medical grounds, during 2013 and since applied to restore their licence and the average timescale for processing these applications:</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 13/05/2014 12:00:00 answering member 1585 label Biography information for Stephen Hammond attachment 1 file name 197757 - table.doc title Tables showing breakdown - driving licneces
	tabling member	4141 label Biography information for Eric Ollerenshaw

50156

	registered interest
	date	07/05/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, which protocols are used in hospitals for withdrawal treatment following long and short-term use of benzodiaepines and Z-drugs.
	tabling member constituency	Lancaster and Fleetwood
	tabling member printed	Eric Ollerenshaw
	uin	198059
	answer	answer is ministerial correction date of answer 14/05/2014 answer text <p>NHS England works with system partners, including training agencies, professional bodies and professional regulators to urge that staff, including those working in hospitals, are appropriately trained, supervised and appraised to monitor practice. In mental health, NHS England is exploring how to modernise the electronic care records system so that it is easier for appropriate prescribing and monitoring to be undertaken.</p><p> </p><p>The Secretary of State and NHS England would also expect hospitals to take account of relevant National Institute for Health and Care Excellence guidance.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 198058 question first answered 14/05/2014 12:00:00 answering member 1439 label Biography information for Norman Lamb
	tabling member	4141 label Biography information for Eric Ollerenshaw

50157

	registered interest
	date	07/05/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department takes to prevent to over-prescribing of psychotropic drugs in hospitals.
	tabling member constituency	Lancaster and Fleetwood
	tabling member printed	Eric Ollerenshaw
	uin	198058
	answer	answer is ministerial correction date of answer 14/05/2014 answer text <p>NHS England works with system partners, including training agencies, professional bodies and professional regulators to urge that staff, including those working in hospitals, are appropriately trained, supervised and appraised to monitor practice. In mental health, NHS England is exploring how to modernise the electronic care records system so that it is easier for appropriate prescribing and monitoring to be undertaken.</p><p> </p><p>The Secretary of State and NHS England would also expect hospitals to take account of relevant National Institute for Health and Care Excellence guidance.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 198059 question first answered 14/05/2014 12:00:00 answering member 1439 label Biography information for Norman Lamb
	tabling member	4141 label Biography information for Eric Ollerenshaw

50158

	registered interest
	date	07/05/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what data his Department collects on prescriptions dispensed to prisoners.
	tabling member constituency	Lancaster and Fleetwood
	tabling member printed	Eric Ollerenshaw
	uin	198140
	answer	answer is ministerial correction date of answer 14/05/2014 answer text <p>Information on the number of prisoners who are prescribed a particular medicine or class of medicine is not collected centrally, nor are data held relating to prescription items dispensed in prisons.</p><p> </p><p>NHS England commissions all pharmacy services in prisons in England. It is responsible for the quality of service and for ensuring that good practice guidelines are followed in relation to the prescribing, safe use and treatment following withdrawal of psychotropic drugs treatments, including benzodiapines and Z-drugs. Where healthcare professionals have concerns about prescribing decisions in relation to psychotropic drug treatment in prisons, they should record these as medication safety incidents and report them to the local medicines management committee for possible further investigation. NHS England commissioners also require healthcare providers to report these incidents in patient safety contract monitoring.</p><p> </p><p>Prison pharmacy services currently follow guidelines set out in <em>A Pharmacy Service for Prisoners</em>, issued by the Department in 2003. NHS England is currently reviewing this guidance, and updated guidance will be published in due course. A copy of the current guidance has already been placed in the Library.</p><p> </p><p>Detailed guidance on benzodiazepine detoxification for prisoners is included in <em>Clinical Management of Drug Dependence in the Adult Prison Setting</em>, published by the Department in 2006. A copy has already been placed in the Library. Clinicians are expected to follow this and other relevant guidance such as that published by the Royal College of General Practitioners' Secure Environments Group on <em>Safer Prescribing in Prisons</em>.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 198060 198061 question first answered 14/05/2014 12:00:00 answering member 1439 label Biography information for Norman Lamb
	tabling member	4141 label Biography information for Eric Ollerenshaw

50159

	registered interest
	date	07/05/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department is taking to prevent over-prescribing or mis-prescribing of psychotropic drugs to prisoners.
	tabling member constituency	Lancaster and Fleetwood
	tabling member printed	Eric Ollerenshaw
	uin	198060
	answer	answer is ministerial correction date of answer 14/05/2014 answer text <p>Information on the number of prisoners who are prescribed a particular medicine or class of medicine is not collected centrally, nor are data held relating to prescription items dispensed in prisons.</p><p> </p><p>NHS England commissions all pharmacy services in prisons in England. It is responsible for the quality of service and for ensuring that good practice guidelines are followed in relation to the prescribing, safe use and treatment following withdrawal of psychotropic drugs treatments, including benzodiapines and Z-drugs. Where healthcare professionals have concerns about prescribing decisions in relation to psychotropic drug treatment in prisons, they should record these as medication safety incidents and report them to the local medicines management committee for possible further investigation. NHS England commissioners also require healthcare providers to report these incidents in patient safety contract monitoring.</p><p> </p><p>Prison pharmacy services currently follow guidelines set out in <em>A Pharmacy Service for Prisoners</em>, issued by the Department in 2003. NHS England is currently reviewing this guidance, and updated guidance will be published in due course. A copy of the current guidance has already been placed in the Library.</p><p> </p><p>Detailed guidance on benzodiazepine detoxification for prisoners is included in <em>Clinical Management of Drug Dependence in the Adult Prison Setting</em>, published by the Department in 2006. A copy has already been placed in the Library. Clinicians are expected to follow this and other relevant guidance such as that published by the Royal College of General Practitioners' Secure Environments Group on <em>Safer Prescribing in Prisons</em>.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 198061 198140 question first answered 14/05/2014 12:00:00 answering member 1439 label Biography information for Norman Lamb
	tabling member	4141 label Biography information for Eric Ollerenshaw

50160

	registered interest
	date	07/05/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, which protocols are used in prisons for withdrawal of treatment following long and short-term use of benzodiazepines and Z-drugs.
	tabling member constituency	Lancaster and Fleetwood
	tabling member printed	Eric Ollerenshaw
	uin	198061
	answer	answer is ministerial correction date of answer 14/05/2014 answer text <p>Information on the number of prisoners who are prescribed a particular medicine or class of medicine is not collected centrally, nor are data held relating to prescription items dispensed in prisons.</p><p> </p><p>NHS England commissions all pharmacy services in prisons in England. It is responsible for the quality of service and for ensuring that good practice guidelines are followed in relation to the prescribing, safe use and treatment following withdrawal of psychotropic drugs treatments, including benzodiapines and Z-drugs. Where healthcare professionals have concerns about prescribing decisions in relation to psychotropic drug treatment in prisons, they should record these as medication safety incidents and report them to the local medicines management committee for possible further investigation. NHS England commissioners also require healthcare providers to report these incidents in patient safety contract monitoring.</p><p> </p><p>Prison pharmacy services currently follow guidelines set out in <em>A Pharmacy Service for Prisoners</em>, issued by the Department in 2003. NHS England is currently reviewing this guidance, and updated guidance will be published in due course. A copy of the current guidance has already been placed in the Library.</p><p> </p><p>Detailed guidance on benzodiazepine detoxification for prisoners is included in <em>Clinical Management of Drug Dependence in the Adult Prison Setting</em>, published by the Department in 2006. A copy has already been placed in the Library. Clinicians are expected to follow this and other relevant guidance such as that published by the Royal College of General Practitioners' Secure Environments Group on <em>Safer Prescribing in Prisons</em>.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 198060 198140 question first answered 14/05/2014 12:00:00 answering member 1439 label Biography information for Norman Lamb
	tabling member	4141 label Biography information for Eric Ollerenshaw

50600

	registered interest
	date	12/05/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether data on prescriptions dispensed in hospitals is collected centrally.
	tabling member constituency	Lancaster and Fleetwood
	tabling member printed	Eric Ollerenshaw
	uin	198382
	answer	answer is ministerial correction date of answer 14/05/2014 answer text <p>There are various sources of data on medicines in hospitals. The Health and Social Care Information Centre publishes annually the document <em>Hospital Prescribing: England</em>, the latest copy of which is available at:</p><p> </p><p>www.hscic.gov.uk/catalogue/PUB12651</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 14/05/2014 12:00:00 answering member 1439 label Biography information for Norman Lamb
	tabling member	4141 label Biography information for Eric Ollerenshaw

61730

	registered interest
	date	12/06/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment he has made of the potential merits of adaptive licensing or early access schemes (a) in the UK and (b) across the EU; and if he will make a statement.
	tabling member constituency	Lancaster and Fleetwood
	tabling member printed	Eric Ollerenshaw
	uin	200378
	answer	answer is ministerial correction date of answer 18/06/2014 answer text <p>The potential merits and impact of adaptive licensing and early access to medicine schemes were considered by the Expert Group on innovation in the regulation of healthcare that was established in June 2012 following the Prime Minister's 2011 Life Science Strategy. The Expert Group was composed of a range of experts from government, industry, patient and health professional stakeholders.</p><p> </p><p>In their 2013 report, the group welcomed the proposal for the Early Access to Medicines Scheme (EAMS), for highly promising unlicensed medicinal products in areas of high unmet medical need, and urged the Government to introduce it as soon as possible. The Medicines and Healthcare products Regulatory Agency launched the EAMS on 7 April 2014.</p><p> </p><p>On adaptive licensing, the group saw opportunities for more use of the existing legal flexibilities to facilitate patient access to innovative products. The Group urged for the pilot on adaptive licensing by the European Medicines Agency (EMA) to be launched at the earliest opportunity.</p><p> </p><p>The EMA published its adaptive licensing pilot project on 19 March. The Government sees this pilot as a test for current licensing flexibilities and the methodology of adaptive licensing. We welcome the pilot and will continue to be actively engaged in the debate in Europe.</p><p> </p><p>A copy of the report of the Expert Group on innovation in the regulation of healthcare has been placed in the Library.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 18/06/2014 14:57:09 answering member 1439 label Biography information for Norman Lamb attachment 1 file name PQ200378 - Lib Doc - Report.pdf title Report
	tabling member	4141 label Biography information for Eric Ollerenshaw

79071

	registered interest
	date	21/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Prescription Drugs: Misuse
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department has taken since 2009 to review policy on addiction to prescription medication; and what the total identifiable costs have been of this review process.
	tabling member constituency	Lancaster and Fleetwood
	tabling member printed	Eric Ollerenshaw
	uin	206669
	answer	answer is ministerial correction date of answer 04/09/2014 answer text <p> </p><p>The Department has been reviewing policy on addiction to prescription medicine over this period, and the Government’s Drug Strategy, published in December 2010, highlights our commitment to reduce dependence on prescription and over the counter medicines.</p><p> </p><p> </p><p> </p><p>In 2009, the Department identified a lack of information on this important subject. The Department commissioned a literature review from the National Addiction Centre and a report from the National Treatment Agency for Substance Misuse (NTA) which interrogated data on specialist treatment and surveyed local commissioners and specialist treatment providers. These reports were peer reviewed and published in May 2011. The cost to the Department for the National Addiction Centre literature review was £9,750 and the cost for the NTA review was £80,000.</p><p> </p><p> </p><p> </p><p>The reports informed the discussions of roundtable meetings of expert stakeholders which were convened by the Minister for Public Health to agree action to tackle addiction to medicines. The roundtable produced a consensus statement, endorsed by the Royal College of General Practitioners, the Royal College of Psychiatrists and other organisations which was published in January 2013. The only direct cost to the Department concerning the roundtables, and other meetings, was £1,928.09 in travel expenses for non-Departmental staff.</p><p> </p><p> </p><p> </p><p>Other Departmental costs associated with reviewing policy on addiction to prescription medicine are not separately identifiable.</p><p> </p><p> </p><p> </p><p>Public Health England (PHE) organised a seminar in February 2013 to improve the commissioning of services to treat addiction to medicine, and following the seminar, in June 2013 published a guide for the National Health Service and local authorities on commissioning treatment for dependence on prescription and over-the-counter medicines.</p><p> </p><p> </p><p> </p><p>The Medicines and Healthcare products Regulatory Agency published in March 2013 a learning module on benzodiazepines which includes advice for prescribers on preventing and treating dependence on these medicines.</p><p> </p><p> </p><p> </p><p>In July 2014, with the approval of the Department and the devolved administrations, PHE launched a public consultation on whether there should be an update to the 2007 United Kingdom clinical guidelines on drug misuse and dependence. The guidelines include advice on treating dependence on benzodiazepines.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 04/09/2014 13:40:04 answering member 3918 label Biography information for Jane Ellison
	tabling member	4141 label Biography information for Eric Ollerenshaw

89483

	registered interest
	date	29/08/2014
	answering body	HM Treasury
	answering dept id	14
	answering dept short name	Treasury
	answering dept sort name	CaTreasury
	hansard heading	Fracking: Taxation
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask Mr Chancellor of the Exchequer, what estimate he has made of potential tax revenue to the Exchequer from shale gas and oil products in each region and constituent part of the UK.
	tabling member constituency	Lancaster and Fleetwood
	tabling member printed	Eric Ollerenshaw
	uin	207431
	answer	answer is ministerial correction date of answer 04/09/2014 answer text <p>Reports by the British Geological Survey’s clearly demonstrate the potential for shale gas in the UK. Shale gas has the potential to increase our energy security, generate growth and support thousands of jobs, and the government is doing everything it can to support the safe and sustainable development of shale gas. This is why we introduced the onshore allowance, to incentivise investment in onshore oil and gas projects and kick-start exploration. Last year, the industry also announced that local communities would receive £100,000 when a test well is fracked – and a further 1 per cent of revenues if shale gas is discovered.</p><p> </p><p>More work is needed to determine the extent of the gas that can be technically and commercially recovered. While there is clearly potential for shale gas to provide substantial revenue to the Exchequer in the future, no forecasts have been produced on the scale or timing of the revenue.</p> answering member constituency Witham answering member printed Priti Patel question first answered 04/09/2014 13:55:43 answering member 4066 label Biography information for Priti Patel
	tabling member	4141 label Biography information for Eric Ollerenshaw